November 30, 2023
  • HOME
  • NEWS
  • POLITICS
  • ECONOMY
  • SPORTS
  • PEOPLE
  • PRESS RELEASES
  • HOME
  • NEWS
  • POLITICS
  • ECONOMY
  • SPORTS
  • PEOPLE
  • PRESS RELEASES
International Diplomacy International Diplomacy
top
Ad Here: x
International Diplomacy
  • HOME
  • NEWS
  • POLITICS
  • ECONOMY
  • SPORTS
  • PEOPLE
  • PRESS RELEASES
Menu
  • HOME
  • NEWS
  • POLITICS
  • ECONOMY
  • SPORTS
  • PEOPLE
  • PRESS RELEASES
loading...
Latest Articles
  • UN Security Council Stalls on Gaza Crisis Resolution
  • China Mourns the Sudden Passing of Former Premier Li Keqiang at 68
  • South Asian Nations React to Escalation in Israeli-Palestinian Conflict
  • Canadian Prime Minister Trudeau Faces Diplomatic Challenges and Travel Disruption During G20 Visit to India
  • G20 Summit 2023: African Union Gets Permanent Membership
  • Allegations of Fraud and Corruption Surround Unimed Glory and Christophe Emelee’s Fishing Quota Agreement
  • Former Vice President Mike Pence Expresses Support for Potential Impeachment Inquiry into President Biden’s Foreign Business Dealings
  • THE REMARKABLE HAJJ INITIATIVES: A SOURCE O PRIDE
  • INTO A KING’S MIND
  • Russian propaganda is more convincing than we think.
Home JCVI
UK to offer under-40s alternative to AstraZeneca Covid-19 vaccine given rare blood clot concerns

UK to offer under-40s alternative to AstraZeneca Covid-19 vaccine given rare blood clot concerns

Posted By: Editorial Teamon: May 07, 2021In: NEWSNo Comments

People under the age of 40 in the U.K. are to be offered an alternative to the Oxford-AstraZeneca Covid-19 vaccine, as concerns over links to rare blood clots continue to weigh on its roll out. Speaking at a press conference on Friday, Professor Wei Shen Lim, chair of the U.K.’s Joint Committee on Vaccination and […] Read more

Share 0
Tweet
Share
Share
Share

Advertising

Ad Here: x
Ad Here: x
top
vrp

2018 Powered By GroupW

  • HOME
  • NEWS
  • POLITICS
  • ECONOMY
  • SPORTS
  • PEOPLE
  • PRESS RELEASES